IL6 and cancer: Although IL-6 did not diminish or promote in vivo expansion of CD4+ T cells in response to vaccination, the age-associated increase in IL-6 dampened Th1 differentiation of CD4+ T cells and subsequent induction of tumour-specific CD8+ T cells, and thereby promoted cancer progression in aged mice.